LPCN
LPCN clinical trials: Lipocine Inc.
Every trial on ClinicalTrials.gov where Lipocine Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
LPCN on the catalyst calendar · LPCN registry changes
- Primary completion Aug 2027Sponsor estimatePhase 3NCT07822321Brexanolone Lifting Outcomes Of MomsLipocine Inc. · Depression, PostpartumRecruitingLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 16, 2026ActualPhase 3NCT06979544A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDLipocine Inc. · Depression, PostpartumCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2022ActualPhase 2NCT04685993A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 TrialLipocine Inc. · NASH - Nonalcoholic SteatohepatitisCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 18, 2023ActualPhase 2NCT04874350A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and SarcopeniaLipocine Inc. · Liver CirrhosisCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 24, 2021ActualPhase 2NCT04134091The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic SteatohepatitisLipocine Inc. · Nonalcoholic Steatohepatitis (NASH)CompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 19, 2019ActualPhase 3NCT03868059Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal MenLipocine Inc. · Hypogonadism, MaleCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2017ActualPhase 3NCT03242590Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).Lipocine Inc. · Hypogonadism, MaleCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2017ActualPhase 3NCT03242408Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)Lipocine Inc. · Hypogonadism, MaleCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2015ActualPhase 3NCT02081300Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismLipocine Inc. · Male HypogonadismCompletedLPCNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner